BIOLEXIS
LIVE

Serial Number

99739201

Owner

Biolexis Therapeutics, Inc.

Attorney

PAOLO ANTONIO STRINO

Filing Date

Apr 1, 2026

Add to watchlist:

No watchlists yet
View on USPTO

BIOLEXIS Trademark

Serial Number: 99739201

BIOLEXIS is a trademark filed by Biolexis Therapeutics, Inc. on April 1, 2026. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Biolexis Therapeutics, Inc.

3900 N Traverse Mountain Blvd
Lehi, UT 84043

Entity Type: 03

Trademark Details

Filing Date

April 1, 2026

Registration Date

Not Registered

Published for Opposition

September 29, 2026

Goods & Services

Research and development in the field of small molecule pharmaceuticals; research and development of new small molecule pharmaceutical products; scientific research in the nature of conducting clinical trials in the field of metabolic diseases; scientific research and development in the field of small molecule drugs

Pharmaceutical preparations for the treatment of obesity; pharmaceutical preparations for the treatment of type 2 diabetes; pharmaceutical preparations for the treatment of metabolic diseases; pharmaceutical preparations for the treatment of sarcopenia; pharmaceutical preparations for the treatment of muscle wasting diseases; pharmaceutical preparations for the treatment of cardiovascular diseases; pharmaceutical preparations for the treatment of neurological disorders; pharmaceutical preparations for the treatment of autoimmune diseases; pharmaceutical preparations for the treatment of cancer

Filing History

APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 29, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 26, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 26, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 26, 2026 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 14, 2026 GNRN
NON-FINAL ACTION E-MAILED
Aug 14, 2026 GNRT
NON-FINAL ACTION WRITTEN
Aug 14, 2026 CNRT
ASSIGNED TO EXAMINER
Aug 12, 2026 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 30, 2026 NWOS
APPLICATION FILING RECEIPT MAILED
Apr 1, 2026 MAFR
NEW APPLICATION ENTERED
Apr 1, 2026 NWAP